University of Applied Sciences and Arts Northwestern Switzerland, School of Life Sciences, Institute of Pharma Technology, Gründenstrasse 40, 4132, Muttenz, Switzerland.
Pharm Res. 2013 Dec;30(12):3114-30. doi: 10.1007/s11095-013-0999-2. Epub 2013 Feb 28.
To determine drug precipitation during in vitro lipolysis of a lipid-based drug delivery system (LBDDS) using Raman spectroscopy as a real-time monitoring technique. A second aim was to describe the kinetics of lipolysis-triggered drug precipitation using a theoretical nucleation and growth model.
A model LBDDS containing different concentration of fenofibrate was digested in vitro and drug precipitation was determined after ultracentrifugation and nanofiltration (off-line methods), as well as by Raman spectroscopy (in-line method). Subsequently, a theoretical nucleation and growth model was fitted to the obtained drug crystallization profiles by considering the lipolysis-triggered change in drug solubility.
Compared with standard off-line measurements, Raman spectroscopy enabled a more robust and highly time-resolved analysis of lipolysis-triggered drug precipitation. Although the formulation was rapidly digested, fenofibrate remained in a supersaturated state for several minutes before beginning to crystallize. The in vitro digestion results were in excellent agreement with the theoretical model (R (2) > 0.976).
The combination of real-time Raman spectroscopy and mathematical modeling provided insights into the kinetics of lipolysis-triggered drug crystallization. This knowledge allows a better biopharmaceutical understanding and will, ultimately, lead to the improved development of lipid-based drug formulations.
使用拉曼光谱作为实时监测技术,确定脂质给药系统(LBDDS)体外脂肪分解过程中的药物沉淀。第二个目的是使用理论成核和生长模型描述脂肪分解触发药物沉淀的动力学。
用不同浓度的非诺贝特对模型 LBDDS 进行体外消化,然后通过超速离心和纳滤(离线方法)以及拉曼光谱(在线方法)测定药物沉淀。随后,通过考虑药物溶解度因脂肪分解而发生的变化,将理论成核和生长模型拟合到获得的药物结晶曲线。
与标准离线测量相比,拉曼光谱能够更稳健、更高度地实时分析脂肪分解触发的药物沉淀。尽管制剂迅速被消化,但在开始结晶之前,非诺贝特仍处于过饱和状态几分钟。体外消化结果与理论模型非常吻合(R(2)> 0.976)。
实时拉曼光谱和数学建模的结合提供了对脂肪分解触发药物结晶动力学的深入了解。这种知识有助于更好地理解生物制药,并最终导致改进脂质药物制剂的开发。